GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (NAS:ARAY) » Definitions » Cyclically Adjusted PS Ratio

ARAY (Accuray) Cyclically Adjusted PS Ratio : 0.35 (As of Dec. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Accuray Cyclically Adjusted PS Ratio?

As of today (2024-12-15), Accuray's current share price is $1.92. Accuray's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was $5.56. Accuray's Cyclically Adjusted PS Ratio for today is 0.35.

The historical rank and industry rank for Accuray's Cyclically Adjusted PS Ratio or its related term are showing as below:

ARAY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.27   Med: 0.8   Max: 2.25
Current: 0.35

During the past years, Accuray's highest Cyclically Adjusted PS Ratio was 2.25. The lowest was 0.27. And the median was 0.80.

ARAY's Cyclically Adjusted PS Ratio is ranked better than
89.93% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 2.36 vs ARAY: 0.35

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Accuray's adjusted revenue per share data for the three months ended in Sep. 2024 was $1.013. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.56 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Accuray Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Accuray's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Cyclically Adjusted PS Ratio Chart

Accuray Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.85 0.35 0.69 0.33

Accuray Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.51 0.44 0.33 0.32

Competitive Comparison of Accuray's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Accuray's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accuray's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Accuray's Cyclically Adjusted PS Ratio falls into.



Accuray Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Accuray's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.92/5.56
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accuray's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Accuray's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.013/133.0289*133.0289
=1.013

Current CPI (Sep. 2024) = 133.0289.

Accuray Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 1.260 99.070 1.692
201503 1.238 99.621 1.653
201506 1.285 100.684 1.698
201509 1.124 100.392 1.489
201512 1.356 99.792 1.808
201603 1.283 100.470 1.699
201606 1.171 101.688 1.532
201609 1.060 101.861 1.384
201612 1.063 101.863 1.388
201703 1.174 102.862 1.518
201706 1.348 103.349 1.735
201709 1.086 104.136 1.387
201712 1.186 104.011 1.517
201803 1.168 105.290 1.476
201806 1.326 106.317 1.659
201809 1.108 106.507 1.384
201812 1.173 105.998 1.472
201903 1.173 107.251 1.455
201906 1.331 108.070 1.638
201909 1.009 108.329 1.239
201912 1.095 108.420 1.344
202003 1.096 108.902 1.339
202006 1.041 108.767 1.273
202009 0.931 109.815 1.128
202012 1.044 109.897 1.264
202103 1.101 111.754 1.311
202106 1.208 114.631 1.402
202109 1.183 115.734 1.360
202112 1.238 117.630 1.400
202203 1.037 121.301 1.137
202206 1.183 125.017 1.259
202209 1.032 125.227 1.096
202212 1.214 125.222 1.290
202303 1.211 127.348 1.265
202306 1.233 128.729 1.274
202309 1.076 129.860 1.102
202312 1.097 129.419 1.128
202403 1.020 131.776 1.030
202406 1.349 132.554 1.354
202409 1.013 133.029 1.013

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Accuray  (NAS:ARAY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Accuray Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Accuray's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Accuray Business Description

Traded in Other Exchanges
Address
1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Executives
Ali Pervaiz officer: SVP Chief Financial Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Joseph E Whitters director
Michael Hoge officer: Senior VP Global Operations 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Gina Corradetti officer: VP, Corporate Controller 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Jesse Chew officer: SVP and General Counsel 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sandeep Chalke officer: SVP, Chief Commercial Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Suzanne C Winter officer: SVP & Chief Commercial Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Patrick Spine officer: SVP, Chief Admin Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Robert Kill director VIRTUAL RADIOLOGIC CORPORATION, 5995 OPUS PARKWAY, SUITE 200, MINNETONKA MN 55343
Brandon W Green officer: Chief Financial Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Franco N Palomba officer: VP, Chief Accounting Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Byron C Scott director 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Joshua Levine officer: President & CEO 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Mika Nishimura director 471 EL CAMINO REAL, SANTA CLARA CA 95050
Shigeyuki Hamamatsu officer: VP, Finance and CAO 1875 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043